NL7806016A - Nieuwe fthalazinederivaten. - Google Patents

Nieuwe fthalazinederivaten.

Info

Publication number
NL7806016A
NL7806016A NL7806016A NL7806016A NL7806016A NL 7806016 A NL7806016 A NL 7806016A NL 7806016 A NL7806016 A NL 7806016A NL 7806016 A NL7806016 A NL 7806016A NL 7806016 A NL7806016 A NL 7806016A
Authority
NL
Netherlands
Prior art keywords
fthalazine
derivatives
new
new fthalazine
fthalazine derivatives
Prior art date
Application number
NL7806016A
Other languages
English (en)
Dutch (nl)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL7806016A publication Critical patent/NL7806016A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL7806016A 1977-06-03 1978-06-02 Nieuwe fthalazinederivaten. NL7806016A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2358277 1977-06-03

Publications (1)

Publication Number Publication Date
NL7806016A true NL7806016A (nl) 1978-12-05

Family

ID=10198020

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7806016A NL7806016A (nl) 1977-06-03 1978-06-02 Nieuwe fthalazinederivaten.

Country Status (29)

Country Link
US (1) US4289772A (fr)
JP (1) JPS5416488A (fr)
AR (2) AR222013A1 (fr)
AT (2) AT362792B (fr)
AU (1) AU505373B1 (fr)
BE (1) BE867727A (fr)
CA (1) CA1111850A (fr)
DD (1) DD137355A5 (fr)
DE (1) DE2824064A1 (fr)
DK (1) DK248078A (fr)
EG (1) EG13527A (fr)
ES (4) ES470470A1 (fr)
FI (1) FI781753A (fr)
FR (1) FR2392986A1 (fr)
GB (1) GB2000136B (fr)
GR (1) GR74402B (fr)
HU (1) HU179745B (fr)
IL (1) IL54842A (fr)
IN (3) IN148482B (fr)
IT (1) IT1094944B (fr)
LU (1) LU79761A1 (fr)
NL (1) NL7806016A (fr)
NO (1) NO781935L (fr)
NZ (1) NZ187453A (fr)
PL (3) PL116437B1 (fr)
PT (1) PT68126A (fr)
SE (1) SE7806519L (fr)
SU (2) SU856383A3 (fr)
ZA (1) ZA783183B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
IL59619A0 (en) * 1979-03-28 1980-06-30 Pfizer Phthalazine derivatives,their preparation and pharmaceutical compositions containing them
IL62200A (en) * 1980-03-01 1984-09-30 Wyeth John & Brother Ltd Piperidine derivatives,their preparation and pharmaceutical compositions containing them
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
EP0621267A1 (fr) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Dérivés de spiropipéridine et leur utilisation comme fongicides
US5728712A (en) * 1995-05-19 1998-03-17 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
WO1998007430A1 (fr) * 1996-08-20 1998-02-26 Eisai Co., Ltd. Medicament contre les defaillances de l'erection, renfermant un compose a base de pyridazine fondue
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
ES2355139T3 (es) * 2002-08-16 2011-03-23 Janssen Pharmaceutica Nv Compuestos de piperidinilo que unen selectivamente a receptores de integrinas.
US20040224986A1 (en) * 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
CA2625153A1 (fr) 2005-10-21 2007-04-26 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP1981868A2 (fr) * 2006-01-27 2008-10-22 Pfizer Products Inc. Composes derives d aminophthalazine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007110449A1 (fr) 2006-03-29 2007-10-04 Euro-Celtique S.A. Composés de benzènesulfonamide et utilisation de ceux-ci
TW200815353A (en) 2006-04-13 2008-04-01 Euro Celtique Sa Benzenesulfonamide compounds and their use
TW200812963A (en) 2006-04-13 2008-03-16 Euro Celtique Sa Benzenesulfonamide compounds and the use thereof
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2377531A2 (fr) 2006-05-09 2011-10-19 Braincells, Inc. Neurogénèse par modulation de l'angiotensine
EP1903037A1 (fr) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft Dérivés de 1-[(hétéro)aryl]-3-[hétéroaryl-pipéridine-4-yl]thiourée en tant que modulateurs de récepteurs EP2
EP1900731A1 (fr) * 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amides comme modulateurs du récepteur EP2
WO2008030651A1 (fr) 2006-09-08 2008-03-13 Braincells, Inc. Combinaisons contenant un dérivé de 4-acylaminopyridine
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8399486B2 (en) 2007-04-09 2013-03-19 Purdue Pharma L.P. Benzenesulfonyl compounds and the use thereof
CA2695211A1 (fr) 2007-08-07 2009-02-12 F. Hoffmann-La Roche Ag Composes de pyrrolidine aryle-ether utilises comme antagonistes des recepteurs nk3
EP2190815B1 (fr) 2007-08-22 2011-08-10 F. Hoffmann-La Roche AG Pyrrolidine aryl-éther en tant qu'antagonistes des récepteurs de nk3
CA2699464A1 (fr) * 2007-09-14 2009-03-19 F. Hoffmann-La Roche Ag Derives de piperidine en tant qu'antagonistes du recepteur nk3
US8765736B2 (en) 2007-09-28 2014-07-01 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
WO2013106547A1 (fr) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation
CN113087654B (zh) * 2021-04-15 2022-12-23 苏州昊帆生物股份有限公司 哌啶-4-丁胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094044A (en) * 1965-07-12 1967-12-06 Vantorex Ltd Phthalazine derivatives
GB1199768A (en) 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1293565A (en) 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
GB1460389A (en) 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
AR223999A1 (es) 1981-10-15
IN149973B (fr) 1982-06-19
SU862826A3 (ru) 1981-09-07
LU79761A1 (fr) 1980-01-22
JPS5538351B2 (fr) 1980-10-03
SE7806519L (sv) 1978-12-04
DE2824064A1 (de) 1978-12-14
ES478200A1 (es) 1980-01-01
IL54842A (en) 1982-01-31
IN149550B (fr) 1982-01-16
ATA400878A (de) 1980-11-15
PL116420B1 (en) 1981-06-30
US4289772A (en) 1981-09-15
ZA783183B (en) 1979-06-27
PL207337A1 (pl) 1979-06-04
AT363096B (de) 1981-07-10
AR222013A1 (es) 1981-04-15
AU505373B1 (en) 1979-11-15
BE867727A (fr) 1978-12-01
EG13527A (en) 1981-12-31
PL116437B1 (en) 1981-06-30
IL54842A0 (en) 1978-08-31
ATA305080A (de) 1980-12-15
HU179745B (en) 1982-12-28
DD137355A5 (de) 1979-08-29
GR74402B (fr) 1984-06-28
AT362792B (de) 1981-06-10
JPS5416488A (en) 1979-02-07
GB2000136B (en) 1982-01-06
FI781753A (fi) 1978-12-04
NZ187453A (en) 1980-12-19
ES478199A1 (es) 1980-01-16
FR2392986A1 (fr) 1978-12-29
PL113208B1 (en) 1980-11-29
ES470470A1 (es) 1979-09-01
IT1094944B (it) 1985-08-10
IT7824106A0 (it) 1978-06-01
NO781935L (no) 1978-12-05
ES478201A1 (es) 1980-02-01
PT68126A (en) 1978-07-01
CA1111850A (fr) 1981-11-03
IN148482B (fr) 1981-03-07
DK248078A (da) 1978-12-04
FR2392986B1 (fr) 1982-07-16
GB2000136A (en) 1979-01-04
SU856383A3 (ru) 1981-08-15

Similar Documents

Publication Publication Date Title
NL7806016A (nl) Nieuwe fthalazinederivaten.
NL7605526A (nl) Nieuwe tetracyclische derivaten.
NL7803432A (nl) Aceetamidederivaten.
NL7804159A (nl) Nieuwe guanidine-derivaten.
NL7803131A (nl) Nieuwe taurine-derivaten.
NL7804360A (nl) Nieuwe antitumoranthracyclinen. 240478 nieuwe antitumoranthracyclinen.
NO784329L (no) Stilbenderivater.
NL7803296A (nl) Cyclohexaandionderivaten.
NL7805344A (nl) Aminoalkylbenzeenderivaten.
NL7800262A (nl) Oxazolinoazetidine derivaten.
NL7810864A (nl) Nieuwe ftalazine derivaten.
NL7809075A (nl) Nieuwe 2-gesubstitueerde 5-hydroxy-1h-imidazool-4-car- boxamidederivaten.
TR20326A (tr) 1-aril-1,4-dihidro-4 okso-piridazinler
IT7848626A0 (it) Interfenilen 8-aza-9-diossotia11,12-secoprostaglandine
NL7801265A (nl) Nieuwe fosfinezuurderivaten.
NL7800717A (nl) Nieuwe aminoalkoxyfenyl-derivaten.
NL7709808A (nl) Nieuwe uracilderivaten.
NL7801708A (nl) 1-oxadethiacepham-derivaten.
NL7602370A (nl) Nieuwe butyrofenonderivaten.
NL7707949A (nl) Nieuwe fenoxyhydroxypropylamine derivaten.
NL7811070A (nl) 2-imino-imidazolidinederivaten.
NL7808036A (nl) Nitrosoureum derivaten.
NL7801289A (nl) Oxadiazolopyrimidinederivaten.
NL7804359A (nl) Nieuwe anthracycline - analoga. 240478 nieuwe anthracycline - analoga.
NL7800450A (nl) Nieuwe fenylazacycloalkanen.

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed